Month: December 2022

Pfizer, Amgen and Bristol-Myers Squibb bought makers of proven drugs ahead of potential rising competition from generics.

The airline is gearing up to restart regular flights on Friday after putting crew schedules back together manually.

A weekslong outage has pressured U.S. oil prices and complicated some refiners’ operations.

The company’s decisions on reimbursements will affect the finances of thousands of travelers.

A Justice Department complaint alleges that the large drug distributor contributed to the prescription opioid epidemic by failing to report suspicious orders to law enforcement.

Covid-19 issues in China are still hampering manufacturing of Apple’s iPhone, but production is beginning to catch up to demand for the more-expensive Pro models.

Many executives vow to push themselves in 2023, which means it could be time for the rank and file to match their intensity—or at least pretend to.

Elon Musk’s car company is trading back at August 2020 levels amid demand concerns, China production pause.

Energy giant said Europe’s effort to take a bite from surging income discourages investment and its adoption violated rules.

Airline executives and labor leaders point to inadequate technology systems as one reason why a brutal winter storm turned into a debacle. One main culprit: SkySolver, a crew scheduling tool, which was overwhelmed by the task.